AR

Amrita Rajagopalan

Active Director Designated Partner DIN 10177578
DIN 10177578 First appointment May 2023 Primary industry Business Services
Unlock full profile Investments Β· shareholding Β· contact details
Current companies 1 active board seats
Total affiliations 1 Since May 2023
Shareholding value β€’β€’β€’β€’ Premium profile

About Amrita Rajagopalan

Data last updated:

Amrita Rajagopalan is a Designated Partner at Macvey Pharma Llp (since 2023). The company operates in Business Services.

DIN 10177578
Primary Designation Designated Partner
Industry Business Services
First Appointment 26 May 2023
Oldest Company Age 3 yrs

Current companies

CompanyDesignationAppointmentFoundedRevenueStatus
Designated Partner26 May 20232023Active

Board colleagues of Amrita Rajagopalan

NameDINCompanyDesignation
Sheela10177580Macvey Pharma LlpDesignated Partner
Sathish Kumar Varikkat Ravindra Nathan11360276Macvey Pharma LlpDesignated Partner

Directorship timeline

Open interactive timeline →
Macvey Pharma Llp
Premium access

Shareholding and investment profile for Amrita Rajagopalan

Company-level share counts, filed values, and quarterly changes require authenticated premium access.

  • Company-level holdings
  • Filed share counts
  • Reported values
  • Quarterly changes
Unlock shareholding

Verified entity values are shown only after access is granted.

Frequently Asked Questions about Amrita Rajagopalan

Amrita Rajagopalan currently holds 1 directorship: Macvey Pharma Llp (Designated Partner, since 26 May 2023).

Amrita Rajagopalan was first appointed on 26 May 2023 as Designated Partner at Macvey Pharma Llp.

The current boards of Amrita Rajagopalan's companies include Sheela (Macvey Pharma Llp), Sathish Kumar Varikkat Ravindra Nathan (Macvey Pharma Llp).

Explore millions of companies β€” effortlessly

Access structured, verified intelligence on 7M+ companies across industries, sectors, and global markets. From early-stage startups to large enterprises, discover ownership, leadership, funding, financials, acquisitions, and market signals β€” all in one powerful platform.

Free account with essential features Instant access to company reports Enterprise solutions available